Clemens, Ralf

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

Alberer, M., Gnad-Vogt, U., Hong, H. S., Mehr, K. T., Backert, L., Finak, G., Gottardo, R., Bica, M. A., Garofano, A., Koch, S. D., et al. (2017) · The Lancet

Rabies epidemiology and controlSARS-CoV-2 and COVID-19 Research

Cited by 530

Clinical experience with an inactivated hepatitis A vaccine.

Clemens, R., Safary, A., Hepburn, A., Roche, C., Stanbury, W. J., & Andre, F. E. (1995) · Journal of Infectious Diseases

Hepatitis Viruses Studies and EpidemiologyHepatitis B Virus Studies

Cited by 223

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study

Van Damme, P., De Coster, I., Bandyopadhyay, A. S., Revets, H., Withanage, K., De Smedt, P., Suykens, L., Oberste, M. S., Weldon, W. C., Costa-Clemens, S. A., et al. (2019) · The Lancet

Viral Infections and Immunology ResearchVirology and Viral Diseases

Cited by 141

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: Two clinical trials

De Coster, I., Leroux-Roels, I., Bandyopadhyay, A. S., Gast, C., Withanage, K., Steenackers, K., De Smedt, P., Aerssens, A., Leroux-Roels, G., Oberste, M. S., et al. (2021) · The Lancet

Viral Infections and Immunology ResearchSARS-CoV-2 and COVID-19 Research

Cited by 86

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: Two clinical trials

Sáez-Llorens, X., Bandyopadhyay, A. S., Gast, C., Leon, T. D., DeAntonio, R., Jimeno, J., Caballero, M. I., Aguirre, G., Oberste, M. S., Weldon, W. C., et al. (2021) · The Lancet

Viral Infections and Immunology ResearchVirology and Viral Diseases

Cited by 81

Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial

Asturias, E. J., Bandyopadhyay, A. S., Self, S., Rivera, L., Saez-Llorens, X., Lopez, E., Melgar, M., Gaensbauer, J. T., Weldon, W. C., Oberste, M. S., et al. (2016) · The Lancet

Viral Infections and Immunology ResearchViral gastroenteritis research and epidemiology

Cited by 80

Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: A randomised, controlled, phase 2 clinical trial

Zaman, K., Bandyopadhyay, A. S., Hoque, M., Gast, C., Yunus, M., Jamil, K. M., Mainou, B. A., Konopka-Anstadt, J. L., Hendley, W. S., Vincent, A., et al. (2023) · The Lancet

Viral Infections and Immunology ResearchVirology and Viral Diseases

Cited by 39

Landscaping analysis of immunization progress and program structures in selected middle income Southeast Asian countries

Basa, J. E., Clemens, R., Clemens, S. A. C., & Nicholson, M. (2024) · Vaccine

Vaccine Coverage and HesitancyGlobal Maternal and Child Health

Cited by 5